Literature DB >> 3285573

The pathogenicity and immunologic relationship of a virulent and a tissue-culture-adapted Babesia bovis.

K L Kuttler1, J L Zaugg, C E Yunker.   

Abstract

Babesia bovis grown in tissue culture was used to inoculate 12, 2-year-old Holstein steers. All 12 developed serological evidence of infection but only six had a febrile response of greater than or equal to 40 degrees C, and only one had a demonstrable B. bovis parasitemia. An average modest drop of 19% was observed in packed cell volume (PCV) during the period of reaction. All 12 steers were subsequently challenged with virulent B. bovis: seven on day 78 post inoculation (p.i.), two on day 106 p.i., and three on day 251 p.i. No demonstrable clinical response was observed in any of the 12 steers previously exposed to the tissue-culture organism, whereas severe signs of babesiosis occurred in seven 2-year-old, non-vaccinated control steers given a comparably virulent B. bovis challenge. All seven controls showed a febrile response, B. bovis parasitemias, with an average drop of 55% in PCV and a 28% mortality.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285573     DOI: 10.1016/0304-4017(88)90038-6

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  3 in total

1.  A Comparative Genomic Study of Attenuated and Virulent Strains of Babesia bigemina.

Authors:  Bernardo Sachman-Ruiz; Luis Lozano; José J Lira; Grecia Martínez; Carmen Rojas; J Antonio Álvarez; Julio V Figueroa
Journal:  Pathogens       Date:  2021-03-08

Review 2.  Cultivation of Babesia and Babesia-like blood parasites: agents of an emerging zoonotic disease.

Authors:  Frederick L Schuster
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

3.  A Culture-Adapted Strain of Babesia bovis Has Reduced Subpopulation Complexity and Is Unable to Complete Its Natural Life Cycle in Ticks.

Authors:  Heba F Alzan; Reginaldo G Bastos; Jacob M Laughery; Glen A Scoles; Massaro W Ueti; Wendell C Johnson; Carlos E Suarez
Journal:  Front Cell Infect Microbiol       Date:  2022-02-10       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.